Boiling point	108-112 ºC**
Flash point	22.9±12.0 ºC, 计算值*
Density	0.902±0.06 g/cm3 (20 º
Refractive index	1.4078 (589.3 nm 20 ºC)***

没有数据	没有数据

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

More

Name	CAS

More

Articles

Peer-Reviewed Papers

[Clinical trial on the effect of buphenine, aminophenazone and diphenylpyraline hydrochloride in treating the common cold in children of 6 to 24 months of age].Ericka Montijo-Barrios et al.Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 63(4), 335-343 (2012-03-01) Determination of diphenylpyraline in plasma and urine by high-performance liquid chromatography.K O Ebete et al.Journal of chromatography. B, Biomedical applications, 677(2), 319-323 (1996-03-03) Diphenylpyraline-responsive parkinsonism in cerebrotendinous xanthomatosis: long-term follow up of three patients.T Ohno et al.Journal of the neurological sciences, 182(2), 95-97 (2001-01-04) Simultaneous determination of ten antihistamine drugs in human plasma using pipette tip solid-phase extraction and gas chromatography/mass spectrometry.Chika Hasegawa et al.Rapid communications in mass spectrometry : RCM, 20(4), 537-543 (2006-01-19) Antimycobacterial activity of diphenylpyraline derivatives.Robert Weis et al.European journal of medicinal chemistry, 43(4), 872-879 (2007-08-24) Effects of the histamine H₁ receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward.Erik B Oleson et al.European journal of pharmacology, 683(1-3), 161-165 (2012-03-27) [Parkinsonism associated with cerebrotendinous xanthomatosis].N Shibata et al.Rinsho shinkeigaku = Clinical neurology, 30(9), 978-984 (1990-09-01) Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties.Gennady B Lapa et al.European journal of pharmacology, 506(3), 237-240 (2005-01-04) Simultaneous estimation of phenylpropanolamine HCl, guaiphenesin and diphenylpyraline HCl in syrups by LC.M Vasudevan et al.Journal of pharmaceutical and biomedical analysis, 24(1), 25-31 (2000-12-07) Determination of antihistamines based on the formation of mixed aggregates with surfactants.M P San Andrés et al.The Analyst, 123(5), 1079-1084 (1998-08-26) A possible approach to the suppression of side effects induced by PGE1.Y Nakabou et al.Prostaglandins, leukotrienes, and essential fatty acids, 52(1), 17-20 (1995-01-01) Effects of H1 antihistamines on canine nasal vascular and airway resistances.M A Lung et al.Rhinology, 25(2), 95-100 (1987-06-01)

Remarks